Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 19;11:747950. doi: 10.3389/fonc.2021.747950

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Zhang, Hu, Han, Wang, Ma, Ye, Yuan, Cao, Zhang, Shi, Chen, Wang, Xu, Cheng, Tian, Wang and Lu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Tumor shrinkage after the conversion therapy. (A) Waterfall plot of maximum tumor shrinkage based on the modified response evaluation criteria in solid tumors (mRECIST) per independent imaging review. (B) Radiologic change of case no. 1. Before treatment (first image outside the red dotted line): tumor located in the right liver (outlined in white dotted line) and portal vein tumor thrombus (PVTT) in the right portal vein (yellow arrow). After treatment (outlined in red dotted line): tumor shrinkage (outlined in white dotted line), future liver remnant (FLR) enlargement, cavernous transformation of portal vein, and recanalization of the intrahepatic portal vein (yellow arrow).